Loading market dashboard
BioXcel Therapeutics, Inc.
BTAIHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
BioXcel Therapeutics, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $399.40M | $194.94M - $576.19M | -$239.64M | $1.48 | 1 |
| Dec 2029 | $178.80M | $87.27M - $257.94M | -$107.28M | -$0.62 | 1 |
| Dec 2028 | $63.30M | $30.90M - $91.32M | -$37.98M | -$0.79 | 1 |
| Dec 2027 | $18.93M | $9.24M - $27.31M | -$11.36M | -$1.533 | 2 |
| Dec 2026 | $1.66M | $808.3K - $2.39M | -$993.6K | -$1.668 | 1 |
| Dec 2025 | $559.4K | $273.0K - $806.9K | -$335.6K | -$6.505 | 2 |
| Dec 2024 | $2.21M | $1.08M - $3.19M | -$1.33M | -$24.872 | 3 |
| Dec 2023 | $2.40M | $1.17M - $3.47M | -$1.44M | -$3.322 | 2 |
| Dec 2022 | $1.18M | $595.7K - $1.94M | -$236.2K | -$83.177 | 1 |